### 35935 Federal Register / Vol. 78, No. 115 / Friday, June 14, 2013 / Notices

Ron A. Otten, Director, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention.

[FR Doc. 2013–14156 Filed 6–13–13; 8:45 am]

**BILLING CODE 4163–18–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**[Docket Number CDC–2013–0008; NIOSH– 234]** 

**National Institute for Occupational Health (NIOSH)—Certified B Readers;**  **Training and Testing**

**AGENCY :**  National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

**ACTION :**  Request for information and comment on priority knowledge and competency items to address in training and testing of National Institute for Occupational Health (NIOSH)—certified B Readers.

**SUMMARY :**  The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC, is requesting information from stakeholders and the general public to identify and prioritize competencies currently needed by B Readers. The information obtained will be used in the development of the new digital B Reader program, including training and
examinations.

**DATES :**  Electronic or written comments must be received by August 13, 2013.

**ADDRESSES :**  You may submit comments, identified by CDC–2013–0008 and NIOSH–234, by any of the following methods:

• Federal eRulemaking Portal: http:// www.regulations.gov. Follow the instructions for submitting comments.

• Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS–C34, 4676 Columbia Parkway, Cincinnati, OH

45226.

All information received in response to this notice must include the agency name and docket number (CDC–2013– 0008; NIOSH–234). All relevant comments received will be posted without change to www.regulations.gov, including any personal information provided. To view the notice and related materials, visit http:// www.regulations.gov and enter CDC– 2013–0008 in the search field and click ‘‘Search.’’

**FOR FURTHER INFORMATION CONTACT :**  Simone Tramma, MD, MS, 1600 Clifton Road NE. MS E20, Atlanta, GA 30329– 4018, telephone 404–498–0197.
Background

Chest radiography is a widely applied and important tool for assessing lung health in clinical care, surveillance, research and hazard evaluations of workers exposed to respirable silica, asbestos, coal, beryllium, and other hazardous dusts. Collectively, these dust-induced diseases are called pneumoconioses. The International Labour Office (ILO) International Classification of Radiographs of Pneumoconioses provides a standardized system for classification of chest radiographs that has been widely used by physicians and epidemiologicresearchers in the investigation of workrelated respiratory hazards. For the last four decades, NIOSH has been training physicians and certifying competence in the use of the ILO system to classify film-based chest radiographs. Physicians who pass a rigorous standardized examination offered by NIOSH are designated as B Readers.

Recently, the ILO system was updated to allow the use of digital chest images instead of analog chest radiographs. Similarly, NIOSH updated its Coal Workers’ Health Surveillance Program to allow use of digital chest images. In follow up, NIOSH is now working to update its B Reader training and certification program by developing digital-format training materials and
examinations.

Core knowledge and competencies tobe addressed in an updated digitalformat B Reader training and certification program might include the following:
I—Knowledge

Understand the following: 1. The different types of radiographic abnormalities that are or may be associated with dust exposure.

2. The intention, format, and mechanics of the ILO classification system, including: (a) When to use the classification and

what abnormalities should be classified (b) How the ILO defines abnormalities

for parenchymal and pleural disease (c) The meaning of profusion and how

to use major/minor profusion categories properly (d) The nature and use of standard

films/images in classification
3. Where to find information about how to apply the ILO system. 4. Where to find information on the NIOSH B Reader system.

5. Ethical approaches to classifying radiographs, including: (a) The responsibilities of the reader in

communicating with worker, agency, lawyer, employer readers
6. The effects of technical defects on the appearances covered in the classification.

II—Skills

Ability to accurately and reliably identify and categorize the following according to the ILO classification system: 1. Image quality

(a) Unreadable images (b) Defects in image quality that may

affect its classification 2. Normal radiographs

(a) Borderline normal 3. Small nodular opacities

(a) High profusion (b) Low profusion (c) Reliably classifying profusion as

1/0 or greater; or 0/1 or less. 4. Small linear/irregular opacities

(a) High profusion (b) Low profusion (c) Reliably classifying profusion as

1/0 or greater; or 0/1 or less 5. Reliable classification of Large Opacities (a) Reliably classify presence of large

opacities (b) Reliably classify category of large

opacities 6. Pleural disease

(a) Plaque and diffuse (b) Calcifications (c) Costophrenic angle obliteration (d) Locations 7. Be able to identify and differentiate:

1. Large opacities and confluence of

small opacities (ax) lesions 2. Cancer (ca) and pulmonary

tuberculosis (tb) lesions

Information Needs

Additional data and information are needed to assist NIOSH in determining the knowledge elements and competencies that should be included in B Reader training and certification and how they should be prioritized for emphasis in training and certification testing. Information is particularly needed in response to the following questions:

(1) What knowledge elements and competencies are essential for a B Reader?

(2) What are the most critical knowledge elements and competencies to identify in the B Reader certification and re-certification examinations?


### 35936 Federal Register / Vol. 78, No. 115 / Friday, June 14, 2013 / Notices

(3) What are the key functions of theB Reader certification and recertification examinations grading system, and how should the examinations be graded to accomplish those functions? Should the general approach currently used for grading 1 2 be changed and if yes, how and why?

(4) Should NIOSH consider alternative approaches to maintenance of B Reader certification besides recertification examinations every 4 years? If so, what alternative approaches would be both effective and desirable?

(5) NIOSH seeks to obtain materials, including published and unpublished reports and research findings that will help to answer these questions. NIOSH encourages respondents to provide these materials.

References

1. Morgan RH [1979].Proficiency

Examination of Physicians for Classifying Pneumoconiosis Chest Films. AJR 132:

803–808. 2. Wagner GR, Attfield MD, Kennedy RD,

Parker JE [1992]. The NIOSH B Reader Certification Program-An Update Report. J Occup Med 34(9):879–84.

Dated June 7, 2013. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.

[FR Doc. 2013–14147 Filed 6–13–13; 8:45 am]

**BILLING CODE 4163–19–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**Statement of Organization, Functions, and Delegations of Authority** 

Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 78 FR 30307–30312, dated May 22, 2013) is amended to reorganize the Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention, and to revise the functional statement for the Office of Scientific Integrity, Office of the Director, National Center for Immunization and Respiratory Diseases.

Section C–B, Organization and Functions, is hereby amended as follows: Delete in its entirety the functional statement for the Office of the Director (CAS1), Office of the Associate Director for Science (CAS), and insert the following:

Office of the Director (CAS1). (1) Directs, manages, and coordinates the activities of the OADS; (2) develops goals and objectives, provides leadership, policy formation, scientific oversight, and guidance in program planning and development; and (3) oversees functions of Office of Science Quality, Office of Scientific Integrity, Office of Technology and Innovation, and Special Projects Activity.

After the title and function statement for the Office of Scientific Integrity (CASJ), Office of the Associate Director for Science (CAS), insert the following:

Office of Technology and Innovation (CASK). (1) Promotes and facilitates the development of technology and innovation throughout the spectrum of scientific discovery; (2) provides leadership and expertise to promote and effect the timely transfer of knowledge and technology for development of products and processes that improve public health; (3) manages CDC’s intellectual property (e.g., patents, trademarks, copyrights) and promotes the transfer of new technology from CDC research to the private sector; (4) leads, develops, coordinates, and manages policies and/or activities that assure CDC intellectual property transfer, scientific training and technical assistance; (5) champions and facilitates innovation, collaborations and technology transfers among federal scientists, laboratories, academia and industry; (6) provides leadership and oversight for innovation activities that have the potential to transform the way that CDC and the private sector improve the public’s health; (7) provides consultation and advice to the CDC Office of the Director, Centers/Institute/ Offices, and programs related to technology transfer and innovation; and (8) maintains regular, open, and responsive communication with the CDC science community and other key partners including CDC Office of General Council, National Institute of Health, Department of Health and Human Services and United States Patent and Trademark Office.

Delete in its entirety the functional statement for the Office of Laboratory Science (CVG14), Office of the Director (CVG1), National Center for Immunization and Respiratory Diseases (CVG), and insert the following:

Office of Laboratory Science (CVG14). (1) Provides leadership, expertise and service in laboratory science; (2)represents NCIRD’s interests in crosscutting laboratory services in OID which include, but are not limited to, laboratory information systems, quality management systems and bioinformatics; (3) ensures a safe working environment in NCIRD laboratories; and (4) collaborates effectively with other centers and offices in carrying out its functions.

Dated: June 6, 2013. Sherri A. Berger, Chief Operating Officer, Centers for Disease Control and Prevention.

[FR Doc. 2013–14165 Filed 6–13–13; 8:45 am]

**BILLING CODE 4163–18–M**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Medicare & Medicaid Services** 

**[Document Identifiers CMS–10482]**

**Agency Information Collection Activities: Proposed Collection;**  **Comment Request**

**AGENCY :**  Centers for Medicare & Medicaid Services.

**ACTION :**  Notice.

**SUMMARY :**  The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden.

**DATES :**  Comments must be received by August 13, 2013:

**ADDRESSES :**  When commenting, please reference the document identifier or OMB control number (OCN). To be assured consideration, comments and